Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Victoria Blinder, MD, MSc
Memorial Sloan Kettering Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pan American Center for Oncology Trials
San Juan, Puerto Rico
Recruiting
- Dignity Health
Phoenix, Arizona, United States
Recruiting - New Hampshire Oncology-Hematology, Pa
Concord, New Hampshire, United States
Recruiting - Solinsky Center for Cancer Care
Manchester, New Hampshire, United States
Recruiting - New York City Health and Hospitals
New York, New York, United States
Recruiting - Sanford Health
Fargo, North Dakota, United States
Recruiting - Gibbs Cancer Center
Spartanburg, South Carolina, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Jul 2025
- Primary completion
- 1 Oct 2028
- Completion
- 1 Apr 2029
- Last update posted
- 12 May 2026
- Registered enrollment
- 1,000
- Registry id
- NCT06963723
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.